Full report from the first annual Heart Rhythm Society Research Forum: a vision for our research future, "dream, discover, develop, deliver".

[1]  A. Garfinkel,et al.  Early afterdepolarizations and cardiac arrhythmias. , 2010, Heart rhythm.

[2]  Mark E. Anderson,et al.  Sudden Cardiac Death Prediction and Prevention: Report From a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop , 2010, Circulation.

[3]  L. Etheredge,et al.  Creating a high-performance system for comparative effectiveness research. , 2010, Health affairs.

[4]  J. Poisal,et al.  National health spending projections: the estimated impact of reform through 2019. , 2010, Health affairs.

[5]  R. Page.  The President's page: the Heart Rhythm Society launches new strategic plan. , 2010, Heart rhythm.

[6]  Robert M Califf,et al.  The role of academic health science systems in the transformation of medicine , 2010, The Lancet.

[7]  F. Collins.  Opportunities for Research and NIH , 2010, Science.

[8]  E. Peterson,et al.  Innovative health reform models: pay-for-performance initiatives. , 2009, The American journal of managed care.

[9]  D. Kass.  Pathobiology of cardiac dyssynchrony and resynchronization. , 2009, Heart rhythm.

[10]  K. Filion,et al.  Improving the clinician-scientist pathway: a survey of clinician-scientists. , 2009, Archives of internal medicine.

[11]  J. Kaiser.  Ethics. Private money, public disclosure. , 2009, Science.

[12]  M. Lauer.  Comparative effectiveness research: the view from the NHLBI. , 2009, Journal of the American College of Cardiology.

[13]  N. Estes.  Focusing on the future: a new Heart Rhythm Society strategic plan. , 2009, Heart rhythm.

[14]  D. Levy,et al.  Prevention of Atrial Fibrillation: Report From a National Heart, Lung, and Blood Institute Workshop , 2009, Circulation.

[15]  D. Korn,et al.  New physician-investigators receiving National Institutes of Health research project grants: a historical perspective on the "endangered species". , 2007, JAMA.

[16]  M. Mitka,et al.  Scientists warn NIH funding squeeze hampering biomedical research. , 2007, JAMA.

[17]  E. Zerhouni,et al.  NIH in the Post-Doubling Era: Realities and Strategies , 2006, Science.

[18]  Majid Ezzati,et al.  Eight Americas: Investigating Mortality Disparities across Races, Counties, and Race-Counties in the United States , 2006, PLoS medicine.

[19]  Stephen S. Cha,et al.  Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence , 2006, Circulation.

[20]  G. Rosner,et al.  Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  J P Ornato,et al.  Public-access Defibrillation and Survival after Out-of-hospital Cardiac Arrest Recommended Citation Public-access Defibrillation and Survival after Out-of-hospital Cardiac Arrest , 2022 .

[22]  P. Basch.  Quality of health care delivered to adults in the United States. , 2003, The New England journal of medicine.

[23]  E. McGlynn,et al.  The quality of health care delivered to adults in the United States. , 2003, The New England journal of medicine.

[24]  J. Murabito,et al.  Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality The Framingham Heart Study , 2003, Circulation.

[25]  A. Camm,et al.  Quality of life in patients with silent atrial fibrillation , 2001, Heart.

[26]  J J Heger,et al.  Sudden cardiac death. , 1998, Circulation.

[27]  E. Braunwald.  Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. , 1997, The New England journal of medicine.

[28]  A Hofman,et al.  Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. , 1997, Stroke.

[29]  L. Kuller,et al.  Coronary heart disease mortality and sudden death: trends and patterns in 35- to 44-year-old white males, 1970-1990. , 1995, American journal of epidemiology.

[30]  G. Rosner,et al.  High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  P. Wolf,et al.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.

[32]  J. Jalife,et al.  Cardiac Electrophysiology: From Cell to Bedside , 1990 .

[33]  R. Gillum,et al.  Geographic variation in sudden coronary death. , 1990, American heart journal.

[34]  R. Virmani,et al.  Sudden cardiac death. , 1987, Human pathology.

[35]  A. Belanger,et al.  The Framingham study. , 1976, British medical journal.

[36]  J. Seward,et al.  The changing epidemiology and natural history of nonvalvular atrial fibrillation: clinical implications. , 2004, Transactions of the American Clinical and Climatological Association.